acute myeloid leukemia: are we always dealing with a high-risk disease?
作者信息
Neuendorff Nina Rosa, Hemmati Philipp, Arnold Renate, Ihlow Jana, Dörken Bernd, Müller-Tidow Carsten, Westermann Jörg
机构信息
Department of Hematology, Oncology and Tumor Immunology, Campus Virchow Klinik, Charité University Medicine, Berlin, Germany; and.
Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
出版信息
Blood Adv. 2018 Jun 26;2(12):1409-1411. doi: 10.1182/bloodadvances.2018015594.
Abstract
摘要
相似文献
1
acute myeloid leukemia: are we always dealing with a high-risk disease?急性髓系白血病：我们始终面对的都是高危疾病吗？
Blood Adv. 2018 Jun 26;2(12):1409-1411. doi: 10.1182/bloodadvances.2018015594.
2
BCR-ABL1-negative acute myeloid leukaemia relapsing as BCR-ABL1-positive disease.BCR-ABL1阴性急性髓系白血病复发为BCR-ABL1阳性疾病。
Br J Haematol. 2017 Feb;176(4):514. doi: 10.1111/bjh.14484. Epub 2016 Dec 16.
3
BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features.BCR-ABL阳性急性髓系白血病：一种新的实体？临床和分子特征分析。
Ann Hematol. 2016 Aug;95(8):1211-21. doi: 10.1007/s00277-016-2721-z. Epub 2016 Jun 14.
4
De novo acute myeloid leukemia with Philadelphia chromosome (BCR-ABL) and inversion 16 (CBFB-MYH11): report of two cases and review of the literature.伴有费城染色体（BCR-ABL）和16号染色体倒位（CBFB-MYH11）的新发急性髓系白血病：两例报告并文献复习
Leuk Lymphoma. 2011 Mar;52(3):531-5. doi: 10.3109/10428194.2010.538941. Epub 2011 Feb 1.
5
[Role of molecular screening for common fusion genes in the diagnosis and classification of leukemia].[分子筛查常见融合基因在白血病诊断和分类中的作用]
Beijing Da Xue Xue Bao Yi Xue Ban. 2005 Jun 18;37(3):236-9.
6
7
Conversion from nuclear bilobation to indentation in BCR/ABL1-positive acute myeloid leukemia lacking CD34 and HLA-DR expression.在缺乏CD34和HLA-DR表达的BCR/ABL1阳性急性髓系白血病中，细胞核从双叶状转变为凹陷状。
Ann Hematol. 2015 Jan;94(1):177-9. doi: 10.1007/s00277-014-2133-x. Epub 2014 Jun 13.
8
[Detection of BCR-ABL1 chimeric gene-positive neutrophils in a patient with mixed phenotype acute leukemia].[混合表型急性白血病患者中BCR-ABL1嵌合基因阳性中性粒细胞的检测]
Rinsho Ketsueki. 2013 Nov;54(11):2074-8.
9
Detection of BCR-ABL fusion proteins in patients with leukemia using a cytometric bead array.采用流式细胞微球检测技术检测白血病患者的 BCR-ABL 融合蛋白。
Leuk Lymphoma. 2012 Mar;53(3):451-5. doi: 10.3109/10428194.2011.625100. Epub 2011 Nov 28.
10
[Retrospective Study of Ph/BCR-ABL Acute Myelogenous Leukemia].[Ph/BCR-ABL 急性髓系白血病的回顾性研究]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Aug;25(4):987-991. doi: 10.7534/j.issn.1009-2137.2017.04.005.
引用本文的文献
1
Bilateral visual loss as the initial presentation of chronic myeloid leukemia: a case report.双侧视力丧失作为慢性髓性白血病的初始表现：一例报告
Ann Med Surg (Lond). 2024 Sep 12;86(10):6335-6339. doi: 10.1097/MS9.0000000000002570. eCollection 2024 Oct.
2
Molecular and Clinical Insights in the Increasing Detection of in Adult Acute Myeloid Leukemia Patients.在成人急性髓系白血病患者中，检测到 的分子和临床见解不断增加。
In Vivo. 2024 Jul-Aug;38(4):2016-2023. doi: 10.21873/invivo.13659.
3
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.伊马替尼联合强化化疗治疗伴有 t(9;22)(q34.1;q11.2)/BCR::ABL1 的 AML：DATAML 注册研究。
Blood Cancer J. 2024 May 31;14(1):91. doi: 10.1038/s41408-024-01069-9.
4
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics.针对具有不良遗传学特征的急性髓系白血病的精准医学方法。
Int J Mol Sci. 2024 Apr 11;25(8):4259. doi: 10.3390/ijms25084259.
5
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with fusion.用于伴有融合的急性髓系白血病的异基因造血细胞移植。
EJHaem. 2024 Mar 30;5(2):369-378. doi: 10.1002/jha2.877. eCollection 2024 Apr.
6
[Clinical analysis of allogeneic hematopoietic stem cell transplantation for seven cases of acute myeloid leukemia with BCR::ABL1 fusion].7例BCR::ABL1融合的急性髓系白血病异基因造血干细胞移植的临床分析
Zhonghua Xue Ye Xue Za Zhi. 2023 Dec 14;44(12):995-1000. doi: 10.3760/cma.j.issn.0253-2727.2023.12.005.
7
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management.伴有TP53突变和BCR/ABL1的急性红系白血病：分类与管理中的挑战
Ann Hematol. 2024 Mar;103(3):1013-1014. doi: 10.1007/s00277-023-05561-3. Epub 2023 Nov 29.
8
A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects.伴有NPM1突变的初发急性髓系白血病中STRN3::PDGFRB基因的一种新型亚克隆重排及其致白血病作用。
Cancer Gene Ther. 2023 Nov;30(11):1471-1484. doi: 10.1038/s41417-023-00651-w. Epub 2023 Aug 7.
9
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors.2023年急性髓系白血病的现代风险分层：整合既定和新出现的预后因素。
Cancers (Basel). 2023 Jul 6;15(13):3512. doi: 10.3390/cancers15133512.
10
An interesting case of chronic myeloid leukemia (CML) with T315I mutation raising suspicion of de novo AML, a diagnostic conundrum.一例有趣的慢性髓系白血病（CML）伴T315I突变病例，引发了对原发性急性髓系白血病（AML）的怀疑，这是一个诊断难题。
Clin Case Rep. 2023 May 23;11(5):e5908. doi: 10.1002/ccr3.5908. eCollection 2023 May.
本文引用的文献
1
Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT).异基因造血干细胞移植治疗 BCR-ABL1 阳性 AML 的相对良好结局：来自欧洲血液和骨髓移植学会（EBMT）急性白血病工作组的一项调查。
Am J Hematol. 2018 Jan;93(1):31-39. doi: 10.1002/ajh.24928. Epub 2017 Oct 31.
2
Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.同时伴有BCR-ABL1和CBFB重排的髓系肿瘤：一组10例具有临床侵袭性的肿瘤。
Am J Hematol. 2017 Jun;92(6):520-528. doi: 10.1002/ajh.24710. Epub 2017 Apr 6.
3
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.成人急性髓系白血病的诊断与管理：2017年国际专家小组的欧洲白血病网络（ELN）建议
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
4
Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation.欧洲白血病网对接受异基因干细胞移植的急性髓系白血病患者基因异常的分类的预测意义
Eur J Haematol. 2017 Feb;98(2):160-168. doi: 10.1111/ejh.12815. Epub 2016 Oct 22.
5
BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features.BCR-ABL阳性急性髓系白血病：一种新的实体？临床和分子特征分析。
Ann Hematol. 2016 Aug;95(8):1211-21. doi: 10.1007/s00277-016-2721-z. Epub 2016 Jun 14.
6
Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy.初发Ph+急性髓系白血病的异基因干细胞移植（allo-SCT）：来自法国骨髓移植与细胞治疗协会的一项研究
Bone Marrow Transplant. 2015 Dec;50(12):1586-8. doi: 10.1038/bmt.2015.206. Epub 2015 Sep 14.
7
t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia.t(9;22)作为核心结合因子原发性急性髓系白血病的继发性改变。
Am J Hematol. 2015 Nov;90(11):E211-2. doi: 10.1002/ajh.24143. Epub 2015 Oct 12.
8
Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities.同时存在t(9;22)和inv(16)染色体异常的血液系统恶性肿瘤的特征
Blood Res. 2014 Mar;49(1):22-8. doi: 10.5045/br.2014.49.1.22. Epub 2014 Mar 24.
9
Does BCR/ABL1 positive acute myeloid leukaemia exist?BCR/ABL1 阳性急性髓系白血病是否存在？
Br J Haematol. 2013 May;161(4):541-50. doi: 10.1111/bjh.12301. Epub 2013 Mar 25.
10
Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.前瞻性评估高危急性髓细胞白血病年轻患者接受亲缘全相合和非亲缘全相合造血干细胞移植：德国-奥地利 AMLHD98A 试验。
J Clin Oncol. 2010 Oct 20;28(30):4642-8. doi: 10.1200/JCO.2010.28.6856. Epub 2010 Aug 30.
Zotero 插件